Evidence map›Paper›PMID 38944884›Full record

ArticleEthics & human research

Patient-Reported Outcome Measures in Routine Clinical Practice: Practical Guidance for Institutional Review Boards.

Justin M Bachmann, Molly A Shiflet, Julia R Palacios, Robert W Turer, Grace H Wallace, S Trent Rosenbloom, Todd W Rice

Abstract read
In one paragraph

Article in Ethics & human research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Justin M BachmannAssistant professor of medicine and biomedical informatics and medical director for patient-reported outcomes measurement at Vanderbilt University Medical Center. He is also a staff physician and research scientist at the Veterans Affairs Tennessee Valley Healthcare System.
Molly A ShifletOperations manager for the human research protections program at Vanderbilt University Medical Center.
Julia R PalaciosMedical student at Saint Louis University School of Medicine.
Robert W TurerAssistant professor of emergency medicine at University of Texas-Southwestern Medical Center.
Grace H WallaceClinical/translational research coordinator at Vanderbilt University Medical Center.
S Trent RosenbloomProfessor of biomedical informatics, medicine, pediatrics, and nursing, and is a vice chair of faculty affairs in the Department of Biomedical Informatics at Vanderbilt University Medical Center. He also directs My Health at Vanderbilt, Vanderbilt's patient portal.
Todd W RiceProfessor of medicine and vice president for clinical trial innovation and operations as well as medical director of the human research protections program at Vanderbilt University Medical Center.

Funding

Development of a Tailored Intervention to Increase Veteran Enrollment in Cardiac RehabilitationIK2HX003021 · VA · VETERANS HEALTH ADMINISTRATION · PI BACHMANN, JUSTIN M · 2021 to 2025
–
Health Services ResearchHSRD VA IK2 HX003021Patient-Centered Outcomes Research Institute (PCORI) RCIP-1812-002U.S. Department of Veterans Affairs 1IK2HX003021Veterans Health Administration, Office of Research and Development
6 · The paper itself

Abstract

The use of patient-reported outcome measures (PROMs) is increasingly common in routine clinical practice. As tools to quantify symptoms and health status, PROMs play an important role in focusing health care on outcomes that matter to patients. The uses of PROM data are myriad, ranging from clinical care to survey-based research and quality improvement. Discerning the boundaries between these use cases can be challenging for institutional review boards (IRBs). In this article, we provide a framework for classifying the three primary PROM use cases (clinical care, human subjects research, and quality improvement) and discuss the level of IRB oversight (if any) necessary for each. One of the most important considerations for IRB staff is whether PROMs are being used primarily for clinical care and thus do not constitute human subjects research. We discuss characteristics of PROMs implemented primarily for clinical care, focusing on: data platform; survey location; questionnaire length; patient interface; and clinician interface. We also discuss IRB oversight of projects involving the secondary use of PROM data that were collected during the course of clinical care, which span human subjects research and quality improvement. This framework provides practical guidance for IRB staff as well as clinicians who use PROMs as communication aids in routine clinical practice.

Indexed as

Ethics Committees, ResearchPatient Reported Outcome MeasuresQuality ImprovementHumansSurveys and Questionnairesclinical carehuman subjects researchinstitutional review boardpatient‐centered outcomes researchpatient‐reported outcome measuresquality improvement

Identifiers

PMID38944884
PMCPMC12959264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.